Table 5 Meta-analysis of the association between FCGR3B copy number polymorphism NA1·NA2 and SLE risk.
Population | N | NA1 vs. NA2(allele model) | NA1·NA1 vs. NA1·NA2+NA2·NA2 (recessive model) | NA1·NA1+NA2·NA2 vs. NA2·NA2 (dominant model) | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
OR(95%CI) | POR | Ph | OR(95%CI) | POR | Ph | OR(95%CI) | POR | Ph | ||
Overall | 11 | 0.851(0.772–0.938) | 1.2 × 10−3 | 0.004 | 0.799(0.685–0.933) | 0.005 | 0.182 | 0.825(0.702–0.969) | 0.019 | 0.001 |
Asian | 3 | 0.785(0.697–0.883) | 6.07 × 10−5 | 0.040 | 0.756(0.635–0.898) | 0.002 | 0.116 | 0.684(0.549–0.853) | 7.2 × 10−4 | 0.103 |
Caucasian | 8 | 1.013(0.851–1.205) | 0.888 | 0.060 | 1.006(0.709–1.426) | 0.974 | 0.885 | 1.021(0.806–1.292) | 0.866 | 0.003 |